Phase II study of neoadjuvant chemotherapy and extended surgery for locally advanced gastric cancer.
about
Recent developments and innovations in gastric cancerNeoadjuvant chemotherapy followed by surgery in gastric cancer patients with extensive lymph node metastasisThe utility of MRI for pre-operative T and N staging of gastric carcinoma: a systematic review and meta-analysisNeoadjuvant chemotherapy followed by surgery versus surgery alone for gastric carcinoma: systematic review and meta-analysis of randomized controlled trialsThe Phase 2 Study of "(TOX) Preoperative Chemotherapy" Response Rate and Side Effects in [Locally Advanced Operable Gastric Adenocarcinoma] Patients With Docetaxel, Oxaliplatin and CapcitabineSurgical outcomes in patients with locally advanced gastric cancer treated with S-1 and oxaliplatin as neoadjuvant chemotherapy.Neoadjuvant chemoradiotherapy followed by D2 gastrectomy in locally advanced gastric cancer.Surgical considerations in the treatment of gastric cancer.Clinical characteristics of hepatoduodenal lymph node metastasis in gastric cancerPreoperative multidetector-row computed tomography scan staging for lymphatic gastric cancer spreadRegional Arterial Infusion Chemotherapy improves the Pathological Response rate for advanced gastric cancer with Short-term Neoadjuvant Chemotherapy.Evaluation of FLT-PET/CT usefulness in diagnosis and qualification for surgical treatment of gastric cancer.MDCT features in the differentiation of T4a gastric cancer from less-advanced gastric cancer: significance of the hyperattenuating serosa sign.Evaluation of rational extent lymphadenectomy for local advanced gastric cancer.Questionnaire survey regarding the current status of super-extended lymph node dissection in Japan.Phase I study of neoadjuvant chemoradiotherapy with S-1 plus biweekly cisplatin for advanced gastric cancer patients with lymph node metastasis: -KOGC04-Decreased stage migration rate of early gastric cancer with a new reconstruction algorithm using dual-energy CT images: a preliminary study.Present and future status of gastric cancer surgery.Neoadjuvant chemotherapy for gastric cancer in Japan: a standing position by comparing with adjuvant chemotherapy.Long-term survival outcomes of advanced gastric cancer patients who achieved a pathological complete response with neoadjuvant chemotherapy: a systematic review of the literature.Gastric adenocarcinoma with para-aortic lymph node metastasis: a borderline resectable cancer?Neoadjuvant chemotherapy for gastric cancer: a meta-analysis of randomized, controlled trials.Recursive partition analysis of peritoneal and systemic recurrence in patients with gastric cancer who underwent D2 gastrectomy: Implications for neoadjuvant therapy consideration.A phase II study of preoperative chemotherapy with docetaxel, cisplatin, and S-1 followed by gastrectomy with D2 plus para-aortic lymph node dissection for gastric cancer with extensive lymph node metastasis: JCOG1002.Prognostic factors for survival in patients with pT1 N+ or T2-3 N0 gastric cancer in Japan.The current state of stomach cancer surgery in the world.Neoadjuvant chemotherapy for gastric adenocarcinoma in Japan.Conversion surgery after combination chemotherapy of docetaxel, cisplatin and S-1 (DCS) for far-advanced gastric cancer.The impact of preoperative lymph node size on long-term outcome following curative gastrectomy for gastric cancer.A randomized Phase II trial of systemic chemotherapy with and without trastuzumab followed by surgery in HER2-positive advanced gastric or esophagogastric junction adenocarcinoma with extensive lymph node metastasis: Japan Clinical Oncology Group stImpact of clinical tumor-node-metastasis staging on survival in gastric carcinoma patients receiving surgery.Effectiveness of laparoscopic stomach-partitioning gastrojejunostomy for patients with gastric outlet obstruction caused by advanced gastric cancer.Tumor Biology: Is It Time to Redefine Unresectability? An Extraordinary Case of Gastroesophageal Junctional Adenocarcinoma.A case of advanced gastric cancer achieved a pathological complete response by chemotherapy.Preoperative S-1 and docetaxel combination chemotherapy in patients with locally advanced gastric cancer.Effect of neoadjuvant chemotherapy on postoperative morbidity and mortality in patients with locally advanced gastric cancer.Neoadjuvant chemotherapy for gastric cancer: what are we trying to accomplish?Evaluation of lymph node metastasis in patients with gastric cancer: a comparison of the directionality of lymph node metastasis and the total number of metastatic lymph nodes.Phase II trial of paclitaxel and cisplatin as neoadjuvant chemotherapy for locally advanced gastric cancer.Prophylactic effect of neoadjuvant chemotherapy in gastric cancer patients with postoperative complications.
P2860
Q26751327-69796018-AEA2-425F-AD9C-C46F42CDEAAEQ26775081-9D18F382-525A-4E8F-ACBF-9A16B3CC1F07Q26829107-3269362A-814A-4DA2-A8A9-5F50C1A1008CQ31150068-A1472D0D-A31E-4B3C-A79D-9BDEE4ED0ECAQ34082404-911F09EF-90B5-4925-8F27-9CCE3409E9FCQ35060024-17636AC0-FAEC-4A09-B06B-89E1554FDD31Q35152348-64F5D56D-C1F6-40AC-9915-FC7BCB0D35E8Q35742852-15AC5D2A-6EBE-43D5-B5D0-217A60A7FD3AQ36145277-ED6D96B6-2775-4E6D-8518-65DF0E5685A1Q36316341-C3450907-852E-4CC1-9C78-B7D12E32F144Q36333418-0AC66CB5-A187-44BF-8483-D9DED0B5D1EAQ36936849-48D06D51-EB1F-4BB5-92B8-78371FEB8565Q37127163-A29E18A1-F2B0-48F2-957A-7EDA4092AE2FQ37246927-69BDA25A-0983-4904-A8E9-82FE4A7B15D7Q37263118-0D0BE266-B8D6-4A05-896F-4A3292EB3F41Q37522736-B04F293F-2925-4CDD-A5B5-0B7FF65DF867Q37553589-CA07B171-7312-4AF7-AD24-9BC8065280EBQ37829544-DBDC8D2F-4553-4CE3-9F2B-42D088EE4C9AQ38090980-5BA65B6B-2BDD-419C-9073-60B862BC6A52Q38249890-B9AAEE8F-802E-402C-B222-83554E2EB4D7Q38264664-901CDD13-C24E-485C-98A2-BCFEFA4D5882Q38410192-1C6189A0-ADB5-42D1-81B4-113D37272685Q38803935-BD73C1FB-404E-468C-BD64-743D4BEA3BE3Q38864811-0EDC78B9-9B69-4904-BB80-22FDAB244C7DQ38940234-DE660148-800D-4A8F-971D-E00EA8D2FFF6Q38941340-81335E3E-7D31-4EB3-89BE-CE0A393AD78CQ39155658-CF32F0D1-9538-47E6-99BE-EA35C5625C0AQ39213501-38568EE6-8443-4960-B5C6-C1ECF0D0CDEBQ39526930-A5B35E1B-CB91-4A23-ABFE-60C02D67AED4Q40556214-8610369D-18D2-438F-B993-B10021A9FD15Q40597871-2810400A-4EC6-4CC0-8A9E-A97307C1E45AQ40707105-D64A1069-7745-42BC-B95B-F83DF61D4023Q41788522-BBF57CA6-9EC8-4F4C-8C2B-A9F6F1A05420Q42271670-A25291DE-787F-4911-A961-90285D9A6516Q43805664-94D4594B-4AFC-452E-B364-859516542BFEQ44316617-42D0E652-75B4-47F2-8705-AF273BFA59E3Q45832848-B09D08DF-DC1C-444F-B7D0-17590D9EE046Q45851080-3AFD0286-94A6-4123-8D9F-1C3AEF6BD798Q46344643-39580C89-3571-48D6-B7F9-56B5F198343EQ47393690-5244B57A-3982-49E3-8E6A-6589CB9A35DE
P2860
Phase II study of neoadjuvant chemotherapy and extended surgery for locally advanced gastric cancer.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh-hant
name
Phase II study of neoadjuvant ...... cally advanced gastric cancer.
@en
Phase II study of neoadjuvant ...... cally advanced gastric cancer.
@nl
type
label
Phase II study of neoadjuvant ...... cally advanced gastric cancer.
@en
Phase II study of neoadjuvant ...... cally advanced gastric cancer.
@nl
prefLabel
Phase II study of neoadjuvant ...... cally advanced gastric cancer.
@en
Phase II study of neoadjuvant ...... cally advanced gastric cancer.
@nl
P2093
P356
P1476
Phase II study of neoadjuvant ...... cally advanced gastric cancer.
@en
P2093
K Fujitani
N Fukushima
S Yamamoto
T Yoshikawa
Y Kawashima
P304
P356
10.1002/BJS.6665
P407
P577
2009-09-01T00:00:00Z